(Q38126545)

29 August 2017

title

Therapeutic drugs in the treatment of symptomatic uterine fibroids (English)

1 reference

29 August 2017

1 reference

Friederike Hoellen

1

1 reference

29 August 2017

Georg Griesinger

series ordinal

2

1 reference

29 August 2017

Michael K Bohlmann

series ordinal

3

1 reference

29 August 2017

language of work or name

English

0 references

publication date

6 August 2013

1 reference

Expert Opinion on Pharmacotherapy

29 August 2017

published in

1 reference

29 August 2017

volume

14

1 reference

29 August 2017

issue

15

1 reference

29 August 2017

page(s)

2079-2085

1 reference

Uterine myomas: an overview of development, clinical features, and management.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Racial and ethnic disparities in benign gynecologic conditions and associated surgeries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Uterine leiomyoma: available medical treatments and new possible therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Current and future medical treatments for menometrorrhagia during the premenopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

[Non-invasive thermoablation of symptomatic uterine fibroids with magnetic resonance-guided high-energy ultrasound].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Ulipristal acetate versus leuprolide acetate for uterine fibroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Incidence, aetiology and epidemiology of uterine fibroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Fibroid-associated heavy menstrual bleeding: correlation between clinical features, Doppler ultrasound assessment of vasculature, and tissue gene expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Clinical utility of progesterone receptor modulators and their effect on the endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Chromosomal mosaicisms during prenatal diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Calcium metabolism in premenopausal women treated by a Gn-RH agonist for uterine myoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

GnRH agonists and uterine leiomyomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Safety and effectiveness of different dosage of mifepristone for the treatment of uterine fibroids: a double-blind randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Effect of asoprisnil on uterine proliferation markers and endometrial expression of the tumour suppressor gene, PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Ulipristal acetate versus placebo for fibroid treatment before surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.825607

10.1517/14656566.2013.825607

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference